TripleTree Advises Icario on its Recapitalization by CVC Capital Partners

May 2021
Icario, the healthcare industry’s leading health action company, is pleased to announce that CVC Capital Partners (“CVC”), a leading global private equity firm, has acquired a majority interest in the company through the CVC Growth Partners II fund. The investment will be used to fuel Icario’s next phase of growth.

Read full press release from Icario.
Like most websites we use cookies here, but we don't share your information. By continuing your visit, you accept the use of cookies. Find out more